~~<i id='CDB5D51DAE'><strike id='CDB5D51DAE'><tt id='CDB5D51DAE'><pre id='CDB5D51DAE'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

fashion

author：comprehensive 2025-08-23 06:43:49 - browse：238

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

leisure time

focus

explore

hotspot

knowledge

entertainment

ThePeshaichildren(fromleft):Abubakar,Mohammad,andSufyan.Illustration:STAT;PhotoCourtesyAfteramonths-

WSS

Unique patient identifier: Experts argue the benefits, pitfalls

Taylor Swift shares sweet moment with Kobe Bryant's daughter Bianka at Eras Tour concert

The Biogen Aduhelm mess could happen again

Global cancer cases to surge 77% by 2050, WHO report says

US Marines prepare to be put on commercial ships to deter Iranian harassment in Strait of Hormuz

Pharma needs to include young adults in clinical research

hotspot

fashion

leisure time

Duchenne breakthrough therapy leaves behind pioneering families

Does Medicare's free annual wellness visit do any good?

Dobbs anniversary: the lost opportunity of abortion as health care

Judge in Trump's Jan. 6 case gives attorneys 2 weeks to propose trial date

Supreme Court strikes down use of affirmative action

Teen charged with murder as hate crime in killing of NYC dancer O'Shae Sibley: Sources

Virginia high school admissions case could be legal follow

Surgery pushed Ben Carson to fame

As demand for Covid shots wanes, Moderna seeks its next success

340B reform proposal comes out of Senate working group

focus

Taylor Swift shares sweet moment with Kobe Bryant's daughter Bianka at Eras Tour concert

Updated Covid vaccine has 54% effectiveness, new study suggests

A single Democrat is willing to weaken Medicare negotiation power

Updated Covid vaccine has 54% effectiveness, new study suggests

What’s missing from the debate over nursing home staff minimums

Johnson & Johnson sued for allegedly overpaying for workers' drugs

explore

hotspot

knowledge

entertainment